InterWest invests an average of about $7 - 15 million over the span of their involvement with each company in their portfolio.
Business Model:
Revenue: $44.2M
Employees: 201-500
Address: 2710 Sand Hill Rd
City: Menlo Park
State: CA
Zip: 94025
Country: US
InterWest invests an average of about $7 - 15 million over the span of their involvement with each company in their portfolio. They invest in companies through the full range of venture investment stages, and investments may be staged over several rounds of financing. Although they generally begin their involvement in the early stages of a company&s;s development, they pursue attractive opportunities based on their individual merits rather than their investment stage.
Contact Phone:
+16508548585
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2002 | Cardiac Dimensions | Series B | 12M |
8/2008 | Follica | Series B | 11M |
3/2013 | Osito | Seed Round | 1.1M |
7/2007 | Diatos | Series D | 12.8M |
4/2013 | The RealReal | Series B | 14M |
10/2006 | Advanced Micro-Fabrication Equipment | Series B | 38M |
4/2010 | Marketo | Series D | 10M |
11/2010 | Marketo | Series E | 25M |
10/2006 | Marketo | Series A | 5.4M |
12/2001 | Scale8 | Series C | 25M |
12/2009 | Xirrus | Series D | 20M |
3/2014 | Invuity | Series E | 36M |
12/2007 | Cardiac Dimensions | Series D | 0 |
7/2006 | USGI Medical | Series C | 21M |
7/2012 | Triposo | Series A | 3.5M |
12/2011 | Carwoo | Series A | 6M |
1/2006 | Carbylan Therapeutics | Series A | 7.8M |
9/2012 | Doximity | Series B | 17M |
8/2016 | Restoration Robotics | Venture Round | - |
11/2014 | Restoration Robotics | Series C | 45M |
2/2009 | Tapjoy | Series B | 15M |
5/2014 | Apteligent | Series C | 30M |
9/2016 | Stellar Loyalty | Venture Round | - |
9/2016 | Restoration Robotics | Venture Round | - |
6/2012 | Drais Pharmaceuticals | Series A | 13M |
5/2002 | Participate Systems | Series D | 0 |
9/2000 | Intarcia Therapeutics | Series C | 38M |
5/2013 | Joyus | Series B | 11.5M |
9/2013 | AppMesh | Series A | 3M |
9/2016 | Totango | Series B | 8.3M |
9/2011 | Ribbon | Pre Seed Round | 120k |
10/2000 | IntraLase | Venture Round | 22M |
11/2009 | CubeTree | Series B | 8M |
1/2005 | AccelChip | Series C | 5.3M |
8/2005 | AkaRx | Series A | 6M |
4/2012 | Alt12 Apps | Seed Round | 1.3M |
6/2000 | Southampton Photonics | Series A | 0 |
2/2013 | InVisage Technologies | Series D | 0 |
5/2001 | Anesiva | Series B | 13M |
6/2014 | Benvenue Medical | Series E | 40M |
6/2002 | Salmedix | Series B | 27.5M |
3/2010 | On Demand Therapeutics | Debt Financing | 300k |
5/2006 | AkaRx | Series A | 8.1M |
9/2015 | Polymorph | Series A | 12M |
10/2009 | Achates Power | Series A | 12.1M |
2/2012 | Integrated Diagnostics | Series A | 10M |
9/2014 | OPAL | Series A | 8M |
8/2016 | Wiser Solutions | Venture Round | - |
1/2014 | Crowdpac | Seed Round | 2.5M |
5/2016 | Obalon Therapeutics | Series E | 0 |
2/2006 | SpectraLinear | Series A | 8M |
8/2002 | Covaro Networks | Series A | 16.7M |
9/2005 | Vendavo | Series E | 15M |
4/2005 | Bivio Networks | Venture Round | 16.5M |
3/2004 | Aspreva Pharmaceuticals Corp | Series A | 57M |
5/2007 | Solace Pharmaceuticals | Series A | 15M |
3/2010 | Advanced Micro-Fabrication Equipment | Venture Round | 5.1M |
12/2004 | Intarcia Therapeutics | Series E | 50M |
11/2007 | Carbylan Therapeutics | Series B | 20M |
2/2003 | Brecis Communications | Series C | 20M |
4/1999 | Intarcia Therapeutics | Series B | 12.1M |
4/2011 | Eiger BioPharmaceuticals | Series A | 14.5M |
9/2006 | Quantance | Series A | 7M |
9/2013 | Indi Molecular | Seed Round | 1.5M |
6/2007 | Tapjoy | Series A | 4.6M |
10/2005 | ReVision Optics | Series C | 12M |
2/2010 | Pivot3 | Series D | 25M |
7/2000 | Scale Eight | Series B | 26.5M |
4/2016 | The RealReal | Series E | 40M |
5/2005 | BioMimetic Therapeutics | Series C | 11.8M |
7/2007 | CardioMind | Series C | 11M |
1/2008 | Pivot3 | Series C | 24M |
2/2015 | Pivot3 | Venture Round | 45M |
10/2014 | Pivot3 | Series E | 2M |
4/2011 | INVIDI Technologies | Series D | 0 |
3/2005 | INVIDI Technologies | Series B | 20.3M |
3/2008 | CardioMind | Venture Round | 22M |
11/2007 | Platform Solutions | Series C | 37M |
12/2004 | QuatRx Pharmaceuticals | Series D | 15M |
10/1999 | Tasman Networks | Venture Round | 21M |
3/2010 | Advanced Micro-Fabrication Equipment | Series D | 46M |
6/2008 | OmniPV | Venture Round | 5M |
10/2017 | Achates Power | Series D | 0 |
3/2013 | Hangtime | Seed Round | 3.5M |
6/2012 | Locbox | Venture Round | 5M |
8/2009 | Pelican Imaging | Series A | 7M |
2/2012 | Satori Pharmaceuticals | Venture Round | 15M |
2/2014 | Welltok | Series C | 22.1M |
10/2014 | Braze | Series B | 15M |
12/2004 | Advanced Micro-Fabrication Equipment | Series A | 1M |
6/2013 | Biba | Series B | 15M |
9/2017 | Braze | Series D | 50M |
12/2007 | Arcion Therapeutics | Series A | 8.8M |
10/2008 | Advanced Micro-Fabrication Equipment | Series C | 58M |
9/2005 | Standard BioTools | Series D | 0 |
1/2006 | Staccato Communications | Series C | 18M |
3/2016 | Tizona Therapeutics | Series B | 43M |
1/2019 | Splice Machine | Venture Round | 0 |
8/2011 | Restoration Robotics | Series C | 41M |
6/2014 | Cidara Therapeutics | Series A | 32M |
6/2003 | QuatRx Pharmaceuticals | Series C | 14M |
8/2015 | Wiser Solutions | Series A | 5M |
12/2003 | USGI Medical | Series B | 12M |
2/2012 | SchoolFeed | Seed Round | 1.8M |
3/2008 | Gear6 | Venture Round | 10M |
5/2002 | eNeura Therapeutics | Series A | 1M |
1/2013 | Carbylan Therapeutics | Venture Round | 6M |
7/2002 | Anesiva | Series C | 50.4M |
2/2013 | Gynesonics | Series D | 21M |
7/2015 | Gynesonics | Venture Round | 43M |
1/2007 | Gynesonics | Series B | 16.5M |
12/2002 | Scale Eight | Series D | 4M |
1/2006 | Amplimmune | Series A | 20M |
12/2000 | Alfalight | Series B | 28M |
9/2017 | Aria Systems | Series F | 0 |
8/2015 | Mobee | Series A | 5M |
10/2013 | Pivot3 | Venture Round | 0 |
8/2004 | Avera Pharmaceutical | Series C | 0 |
4/1994 | Ciena | Series A | - |
10/2009 | Integrated Diagnostics | Series A | 30M |
11/2016 | Cheetah Digital | Series A | 9M |
7/2007 | C9 Inc. | Series A | 5M |
6/2007 | ARCA biopharma | Series B | 18M |
5/2007 | CVRx | Series D | 65M |
7/2003 | Southampton Photonics | Series B | - |
8/2000 | Epocrates | Series B | 35M |
12/2018 | Aria Systems | Private Equity Round | 0 |
8/2002 | Epocrates | Series C | - |
10/2009 | Neuronetics | Series D | 0 |
8/2006 | Neuronetics | Series C | 0 |
10/2005 | Nereus Pharmaceuticals | Series D | 0 |
8/2007 | Nereus Pharmaceuticals | Series D | 0 |
3/2014 | Grokker | Series A | 10M |
1/2006 | Archus Orthopedics | Series C | 35M |
6/2003 | Intarcia Therapeutics | Series D | 43M |
6/2015 | Realeve | Series D | 43.2M |
12/2008 | Bivio Networks | Venture Round | 0 |
8/2008 | Brand.net | Series B | 10M |
11/2000 | Bivio Networks | Series A | 20M |
1/2005 | Ample Communications | Series D | 10.4M |
3/2001 | LongBoard | Series B | 24M |
12/2015 | Triposo | Venture Round | 3.1M |
8/2006 | Bivio Networks | Venture Round | 8.5M |
11/2005 | LongBoard | Series D | 4M |
1/2005 | Venturi Wireless | Series C | 10M |
8/2003 | Myogen | Series D | 40M |
9/2000 | Ample Communications | Series A | 17M |
2/2004 | Ample Communications | Series C | 15M |
2/2017 | PMV Pharmaceuticals | Series B | 74M |
2/2009 | Exalt Communications | Series C | 0 |
12/2004 | CardioMind | Series B | 15.1M |
8/2008 | Marketo | Series B | 8M |
7/2012 | Obalon Therapeutics | Series C | 16.5M |
5/2013 | Aviate | Venture Round | 1.8M |
10/2001 | Metro Optix | Series C | 0 |
1/1995 | Corixa | Series A | 15M |
5/2013 | Nanostim | Venture Round | 9.5M |
7/2019 | Welcome | Venture Round | 0 |
5/2009 | Lycera | Series A | 0 |
11/2016 | Grokker | Series B | 7M |
9/2008 | Right90 | Series C | 10M |
6/2014 | Victorious | Series A | 23.2M |
7/2007 | Right90 | Series B | 12M |
4/2015 | The RealReal | Series D | 40M |
1/2014 | Welcome | Series C | 25M |
8/2002 | Varolii | Series C | 15M |
5/2014 | The RealReal | Series C | 20.4M |
6/2004 | Paracor Medical | Series C | 30.5M |
6/2007 | Paracor Medical | Series D | 44M |
1/2001 | Salmedix | Series A | - |
2/2004 | Vendavo | Series D | 6M |
4/2002 | Dynavax Technologies | Series D | 0 |
2/2012 | Pivot3 | Venture Round | 23M |
4/2008 | SignalDemand | Venture Round | 20M |
3/2016 | Eiger BioPharmaceuticals | Debt Financing | - |
8/2011 | Get Satisfaction | Series B | 10M |
10/2003 | Anesiva | Series D | 20M |
2/2016 | Aria Systems | Series E | 0 |
1/2015 | Sera Prognostics | Series B | 20M |
7/2008 | MacroGenics | Series D | 12.5M |
1/2016 | Benvenue Medical | Equity | 23M |
9/2013 | HireArt | Seed Round | 1.4M |
5/2010 | INVIDI Technologies | Series D | 0 |
12/2007 | INVIDI Technologies | Series C | 0 |
5/2016 | Braze | Series C | 20M |
12/2014 | InVisage Technologies | Series F | 32.5M |
8/2014 | Pivot3 | Series E | 0 |
1/2008 | Follica | Series A | 5.5M |
9/2005 | C9 Inc. | Series A | 0 |
10/2021 | GoCheck | Venture Round | 0 |
9/2013 | C9 Inc. | Series D | 0 |
3/2016 | TESARO | Post-IPO Equity | 155M |
4/2001 | Xenon Pharmaceuticals | Venture Round | 45M |
10/2013 | Achates Power | Series C | 35.2M |
4/2014 | InVisage Technologies | Series E | 0 |
8/2014 | Splice Machine | Series B | 18M |
3/2007 | Advanced Micro-Fabrication Equipment | Series B | 8M |
12/2014 | PMV Pharmaceuticals | Series A | 30M |
6/2002 | MacroGenics | Venture Round | 12.6M |
2/2015 | Invuity | Equity | 22.9M |
10/2008 | MacroGenics | Series D | 25M |
7/2014 | Gynesonics | Debt Financing | 28.4M |
1/2018 | Gynesonics | Private Equity Round | 75M |
11/2015 | Avedro | Series E | 32M |
4/2017 | Avedro | Venture Round | 0 |
12/2016 | Integrated Diagnostics | Series C | 6.1M |
11/2013 | GAIN Fitness | Angel Round | 2.1M |
3/2010 | Avaak | Series B | 10M |
5/2010 | C9 Inc. | Series C | 8M |
6/2016 | Khoros | Series F | 50M |
10/2008 | Avaak | Series A | 7M |
7/2006 | Gear6 | Series C | 10M |
4/2007 | NovaCardia | Series B | 18M |
7/2012 | Gojee | Venture Round | 2.8M |
3/2007 | Open-Silicon | Series D | 10M |
4/2008 | NexPlanar | Series C | 0 |
2/2013 | Spredfast | Series C | 18M |
9/2007 | Sequel Pharmaceuticals | Series A | 20M |
5/2006 | Eledon Pharmaceuticals | Series B | 35M |
12/2001 | Again Technologies | Series C | 0 |
11/2015 | Celladon | Post-IPO Equity | 39.5M |
6/2015 | Joyus | Series C | 0 |
4/1999 | Applied Science Fiction | Venture Round | 31.5M |
9/2000 | Chiaro Networks | Series C | 100M |
12/2010 | Flurry | Series C | 15M |
4/2014 | Doximity | Series C | 54M |
5/2019 | Aryaka Networks | Series F | 0 |
8/2007 | Restoration Robotics | Series B | 25M |
1/2018 | Centrexion | Series D | 67M |
7/2008 | CVRx | Series E | 0 |
9/2011 | Spredfast | Series B | 12M |
8/2008 | Glaukos | Series D | 35M |
9/2011 | Khoros | Series B | 12M |
4/2019 | GoCheck | Series B | 0 |
12/1999 | LoanCity.com | Series B | 0 |
9/2005 | Nuventix | Series A | 6.5M |
11/2004 | Voyence | Venture Round | 0 |
4/2014 | Integrated Diagnostics | Series B | 31.7M |
3/2000 | GoToMyDoc | Venture Round | 25M |
6/2011 | TESARO | Series B | 101M |
6/2018 | Bolt | Series B | 0 |
7/2009 | C9 Inc. | Series B | - |
3/2007 | Transcept Pharmaceuticals | Series D | 40M |
6/2012 | AppMesh | Seed Round | 900k |
10/2016 | Welltok | Series E | 0 |
1/2000 | Net32 | Venture Round | 12M |
8/2004 | Platform Solutions | Series B | 13.2M |
10/2014 | Stellar Loyalty | Series A | 5M |
3/2016 | Bigstep | Seed Round | 0 |
1/2009 | Satori Pharmaceuticals | Series A | 22M |
4/2014 | Polymorph | Seed Round | 2.2M |
11/2011 | Sera Prognostics | Series A | 19.3M |
4/2013 | Piggybackr | Seed Round | 325k |
4/2003 | Neuronetics | Series A | 15M |
3/2005 | Neuronetics | Series B | 8.5M |
6/2011 | Empowered Careers | Series A | 15M |
8/2004 | Platform Solutions | Series A | 10.2M |
10/2005 | Radiant Medical | Venture Round | 36M |
11/2009 | Calypso Medical | Series E | 50M |
10/2006 | AkaRx | Series A | 2M |
12/2003 | Avera Pharmaceutical | Series B | 8M |
11/2002 | Again Technologies | Series D | 6.5M |
2/2009 | Eiger BioPharmaceuticals | Series A | 8.3M |
12/1994 | Ciena | Series B | - |
10/2000 | Elitra Pharmaceuticals | Venture Round | 0 |
3/2013 | Canva | Seed Round | 6.6M |
6/2011 | Virsto | Series B | 12M |
6/2000 | Broadband Gateways | Venture Round | 0 |
7/2013 | ReVision Optics | Series E | 55M |
5/2006 | KAI Pharmaceuticals | Series B | 35M |
8/2016 | GoCheck | Series B | 6M |
3/2015 | Aryaka | Series E | 16M |
12/2003 | KAI Pharmaceuticals | Series A | 17M |
7/2012 | Aryaka Networks | Series C | 25M |
6/2014 | Aryaka | Series C | 10M |
2/2005 | Pivot3 | Series B | 9M |
5/2002 | LongBoard | Series C | 10.3M |
1/2006 | NovusEdge | Series B | 6.5M |
12/2011 | GAIN Fitness | Seed Round | 650k |
4/2004 | Staccato Communications | Series B | 20M |
11/2008 | Staccato Communications | Venture Round | 20M |
1/2015 | Welltok | Series D | 0 |
10/2005 | eNeura Therapeutics | Series B | 5.1M |
9/2016 | C3 AI | Series D | 70M |
8/2007 | Vizionware | Series B | 8.2M |
7/2013 | Swell | Series A | 5.4M |
1/2015 | Obalon Therapeutics | Series D | 0 |
4/2000 | Participate Systems | Series B | 0 |
6/2000 | Brecis Communications | Series A | 20.5M |
10/2003 | Sierra Logic | Series C | 32M |
9/2002 | Sierra Logic | Series B | 12M |
9/2010 | Cebix | Venture Round | 16M |
1/2011 | Tapjoy | Series C | 21M |
11/2004 | BioMimetic Therapeutics | Series C | 25.7M |
10/2012 | Cebix | Series B | 0 |
6/2009 | Applied Genetics Technologies Corporation | Venture Round | 11.8M |
12/2006 | Ophthonix | Series D | 35.1M |
12/2012 | Labrys Biologics | Venture Round | 14.6M |
1/2013 | Labrys Biologics | Series A | 31M |
12/2017 | Splice Machine | Series B | 0 |
2/2007 | Trius Therapeutics | Series A | 20M |
10/2010 | Carwoo | Series A | 4.5M |
11/2003 | Applied Genetics Technologies Corporation | Venture Round | 27M |
3/2014 | DataRPM | Series A | 5.1M |
11/2012 | Applied Genetics Technologies Corporation | Series B | 0 |
7/2018 | The RealReal | Series G | 115M |
1/2008 | PrimeraDx (Primera Biosystems) | Series B | 21M |
7/2013 | NeuroPace | Venture Round | 18M |
5/2013 | Pelican Imaging | Series C | 20M |
1/2012 | Invuity | Venture Round | 2M |
9/2005 | Open Silicon | Series C | 15.1M |
4/2013 | Quantance | Series D | 12M |
5/2012 | Badgeville | Series C | 25M |
2/2016 | Stellar Loyalty | Series A | 4M |
11/2006 | SpectraLinear | Series B | 14M |
1/2009 | SpectraLinear | Series C | 10M |
3/2011 | NexPlanar | Series D | 10M |
1/2001 | Brecis Communications | Series B | 0 |
6/2010 | Brand.net | Series C | 14M |
2/2012 | Optimizely | Seed Round | 2M |
11/2012 | Flurry | Series D | 0 |
1/2005 | NeuroPace | Venture Round | 30M |
1/2016 | Crowdpac | Series A | 6M |
3/2008 | Spiration | Series G | 18.5M |
2/2002 | Chiaro Networks | Series D | 80M |
1/2008 | Nuventix | Series A | 8.5M |
7/2010 | ReVision Optics | Series D | 35M |
9/2015 | Welcome | Series D | 42M |
11/2016 | ReVision Optics | Venture Round | 32M |
5/2011 | Neuronetics | Series E | 30M |
7/2000 | Metro Optix | Series B | 63M |
4/2000 | Metro Optix | Series A | 28M |
5/2007 | QuatRx Pharmaceuticals | Series E | 0 |
1/2016 | Tizona Therapeutics | Series A | 27M |
10/2004 | MacroGenics | Series B | 30.5M |
3/2016 | Potenza Therapeutics | Venture Round | 30M |
5/2006 | MacroGenics | Series C | 45M |
9/2001 | MacroGenics | Series A | 13.5M |
2/2018 | Totango | Series C | 9M |
9/2006 | Alvine Pharmaceuticals | Series A | 21.5M |
3/2015 | Aryaka | Series C | 16M |
8/2003 | Archus Orthopedics | Series B | 18M |
10/2009 | PrimeraDx (Primera Biosystems) | Series C | 20M |
2/2013 | Khoros | Series C | 18M |
1/2014 | Spredfast | Series D | 32.5M |
5/2007 | Lombardi Software | Series D | 8M |
6/2017 | Neuronetics | Series G | 0 |
1/2010 | MicroCHIPS | Venture Round | 16.5M |
4/2013 | Welltok | Series B | 18.7M |
3/2004 | Cardiac Dimensions | Series C | 15M |
3/2011 | Doximity | Series A | 10.8M |
2/2011 | Atria Systems | Series C | 27.2M |
1/2006 | Lombardi Software | Series C | 12M |
3/2004 | Lombardi Software | Venture Round | 0 |
11/2013 | Aria Systems | Series D | 0 |
8/2011 | Bloomspot | Series B | 35M |
4/2014 | Damballa | Series E | 13M |
4/2013 | Flurry | Venture Round | 255k |
12/2013 | Flurry | Series D | 12.5M |
9/2004 | Silicon Optix | Series C | 40M |
1/2004 | Spiration | Series E | 0 |
4/2006 | Cape Clear Software | Series D | 15M |
5/2007 | Cape Clear Software | Series E | 5M |
9/2008 | APT Pharmaceuticals | Series B | 32M |
2/2013 | Glaukos | Series F | 30M |
4/2006 | Spiration | Series F | 13.4M |
3/2009 | LensX Lasers | Series B | 22.4M |
8/2001 | Myogen | Series D | 52.4M |
1/2011 | Satori Pharmaceuticals | Series B | 7M |
1/2010 | Flurry | Series B | 7M |
12/2011 | Amaze Software, Inc | Seed Round | 1.1M |
9/2008 | Microfabrica | Series B | 22.5M |
2/2014 | Totango | Series A | 15.5M |
12/1995 | Ciena | Series C | - |
7/2011 | Varolii | Series D | 8M |
9/2012 | Xirrus | Series E | 23.5M |
4/2005 | T-RAM Semiconductor | Series C | 40M |
7/2013 | Concept.io Inc. | Series A | 5.4M |
11/2011 | Marketo | Series F | 50M |
10/2007 | Staccato Communications | Venture Round | 17.5M |
5/2015 | Realeve | Series D | 38M |
5/2009 | Realeve | Series B | 20M |
10/2005 | Ophthonix | Series C | 17M |
6/2012 | Invuity | Series D | 25M |
2/2011 | InVisage Technologies | Series C | 0 |
2/2011 | Damballa | Series D | 12M |
6/2016 | Spredfast | Series F | 50M |
11/2019 | PMV Pharmaceuticals | Series C | 0 |
11/2013 | Ocera Therapeutics | Post-IPO Equity | 0 |
4/2013 | Optimizely | Series A | 28M |
1/2014 | Khoros | Series D | 32.5M |
1/2012 | Flotype | Seed Round | 1.4M |
5/2018 | Avedro | Series F | 0 |
12/1999 | Vendavo | Series B | 30.5M |
1/2015 | Cuyana | Venture Round | - |
5/2000 | ChipData | Series A | 10M |
12/2016 | Restoration Robotics | Venture Round | - |
6/2008 | NexPlanar | Series C | 0 |
1/2006 | RedShift BioAnalytics | Series A | 12M |
7/2000 | RHK | Series A | - |
7/2007 | Convey Computer | Series A | 16M |
4/2000 | Chiaro Networks | Series B | 18M |
8/2001 | Scale Eight | Series C | 23M |
5/2003 | AccelChip | Series B | 6.7M |
4/2002 | Avera Pharmaceutical | Series A | 20M |
10/2012 | Nanostim | Venture Round | 10M |
12/2004 | ReVision Optics | Series C | 5.5M |
8/2011 | Virsto | Series B | 5M |
11/2008 | Quantance | Series B | 12M |
9/1999 | Participate Systems | Series A | 0 |
9/2007 | Kajeet | Series B | 36.8M |
10/2010 | Pelican Imaging | Series B | 10M |
9/2011 | Quantance | Series C | 11M |
11/2007 | Brand.net | Series A | 3M |
12/2000 | InnovICs Wireless | Series B | 7M |
1/2015 | Knotch | Venture Round | - |
1/2017 | Vidora | Seed Round | - |
7/2009 | Convey Computer | Series B | 0 |
7/2011 | Nuventix | Venture Round | 0 |
11/2009 | Standard BioTools | Venture Round | 0 |
6/2006 | ReVision Optics | Series C | 3M |
1/2006 | Kajeet | Series A | 27M |
9/2006 | NovaCardia | Series B | 48M |
12/2016 | Centrexion | Series C | 47.6M |
1/2004 | Standard BioTools | Series D | 21M |
11/2001 | Standard BioTools | Series C | 34M |
1/2007 | Standard BioTools | Series E | 0 |
10/2021 | GoCheck | Venture Round | 0 |
11/2019 | PMV Pharmaceuticals | Series C | 0 |
7/2019 | Welcome | Venture Round | 0 |
5/2019 | Aryaka Networks | Series F | 0 |
4/2019 | GoCheck | Series B | 0 |
1/2019 | Splice Machine | Venture Round | 0 |
12/2018 | Aria Systems | Private Equity Round | 0 |
7/2018 | The RealReal | Series G | 0 |
6/2018 | Bolt | Series B | 0 |
5/2018 | Avedro | Series F | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|